期刊文献+

α-硫辛酸注射液联合甲钴胺治疗糖尿病周围神经病变30例 被引量:6

α-Lipoic Acid Injection Combined Methycobal in Treating Diabetic Peripheral Neuropathy in 30 Cases
下载PDF
导出
摘要 目的观察α-硫辛酸注射液联合甲钴胺治疗糖尿病周围神经病变的疗效。方法将60例患者随机分为治疗组和对照组各30例,在治疗糖尿病的同时,治疗组加用α-硫辛酸注射液600 mg静脉滴注,甲钴胺500μg,口服,1日3次;对照组加用甲钴胺500μg,口服,1日3次,3周为1个疗程。结果治疗组总有效率为93.33%,高于对照组的66.67%(P<0.05),两组均未出现明显不良反应。结论α-硫辛酸注射液联合甲钴胺治疗糖尿病周围神经病变疗效确切。 Objective To observe the clinical efficacy of α- Lipoic Acid Injection combined methycobal in treating diabetic peripheral neuropathy(DPN). Methods Sixty cases of DPN were randomly divided into the treatment group and the control group. The normal diabetic therapy was adopted in the two groups. At the same time, the treatment group was added with Alpha- Lipoic Acid Injection 600 mgmby intravenous drip, once daily, and oral methycobal 500μg, 3 times daily; the control group was added with oral methycobal 500μg, 3 times daily. The therapeutic course lasted for 3 weeks. Results The overall effective rate was 93.33% in the treatment group and 66. 67% in the control group, showing statistically significant difference between the two groups(P〈0.05). No evident adverse reactions were observed in both groups. Conclusion The combined therapy of α- Lipoic Acid Injection and methycobal is definitely effective in the treatment of DPN.
出处 《中国药业》 CAS 2013年第9期62-63,共2页 China Pharmaceuticals
关键词 α-硫辛酸注射液 糖尿病周围神经病变 甲钴胺 α- lipoic acid injection diabetic peripheral neuropathy methycobal
  • 相关文献

参考文献6

二级参考文献140

共引文献1724

同被引文献50

  • 1郭蔚莹,刘艳,朱丹.2型糖尿病合并周围神经病变内皮素及一氧化氮水平监测[J].中国实验诊断学,2005,9(3):413-414. 被引量:8
  • 2王春梅,刘艳,孙立娟.血清ET、TNF、NO水平在2型糖尿病周围神经病变中的作用[J].中国老年学杂志,2006,26(5):604-606. 被引量:9
  • 3陆红,吴慧萍.一氧化氮在2型糖尿病周围神经病变中的作用[J].实用诊断与治疗杂志,2006,20(6):398-400. 被引量:8
  • 4张蜀平,游志清,宋晓峰,黄欣.糖尿病神经病变的药物治疗进展[J].西南军医,2007,9(2):77-78. 被引量:1
  • 5郑白蒂,胡国贤,朱禧星,等.糖尿病性神经病变治疗的探讨[J].中华内科杂志,1981,20(9):523-525.
  • 6Nath 1, Nath CK, Baruah M, et al. A Study of Inflammatory Status in Nephropathy Patients with History of Type - Ⅱ Diabetes Mellitus Undergo-ing Haemodialysis[ J]. J Clin Diagn Res,2013,7(10): 2 143 -2 145.
  • 7Palacka P, Kucharska J, Murin J, et al. Complementary therapy in diabetic patients with chronic complications; a pilot study[J]. Bratial Lek Listy,2010,111(4):205 -211.
  • 8Slangen R,Pluijms WA, Faber CG, et al. Sustained effect of spinal cord stimulation on pain and quality of Life inpainful diabetic peripheral neuropathy[J]. Br J Anaesth, 2013,111 (6) : 1030-1031.
  • 9Dey I, Midha N, Singh G, et al. Diabetic schwann cells suf- fer from nerve growth factor and neurotrophin-3 under- production and poor assoeiability with axons [J]. Glia, 2013,61(12) :1990-1999.
  • 10Vinik AI, Bril V, Litchy WJ, et al. Sural sensory action potential identifies diabetic peripheral neuropathy re- sponders to therapy[J]. Muscle Nerve, 2005,32 ( 5 ) : 619- 625.

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部